Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
317.69
-2.37 (-0.74%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $653.00M in the quarter ending September 30, 2025, with 0.51% growth. This brings the company's revenue in the last twelve months to $2.56B, down -0.88% year-over-year. In the year 2024, Bio-Rad Laboratories had annual revenue of $2.57B, down -3.92%.
Revenue (ttm)
$2.56B
Revenue Growth
-0.88%
P/S Ratio
3.42
Revenue / Employee
$332,143
Employees
7,700
Market Cap
8.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -104.70M | -3.92% |
| Dec 31, 2023 | 2.67B | -131.00M | -4.67% |
| Dec 31, 2022 | 2.80B | -120.35M | -4.12% |
| Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
| Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
| Dec 31, 2019 | 2.31B | 22.24M | 0.97% |
| Dec 31, 2018 | 2.29B | 129.26M | 5.98% |
| Dec 31, 2017 | 2.16B | 91.98M | 4.45% |
| Dec 31, 2016 | 2.07B | 48.73M | 2.41% |
| Dec 31, 2015 | 2.02B | -155.60M | -7.15% |
| Dec 31, 2014 | 2.18B | 42.35M | 1.99% |
| Dec 31, 2013 | 2.13B | 63.46M | 3.07% |
| Dec 31, 2012 | 2.07B | -4.29M | -0.21% |
| Dec 31, 2011 | 2.07B | 146.41M | 7.60% |
| Dec 31, 2010 | 1.93B | 142.87M | 8.01% |
| Dec 31, 2009 | 1.78B | 19.88M | 1.13% |
| Dec 31, 2008 | 1.76B | 303.31M | 20.76% |
| Dec 31, 2007 | 1.46B | 187.12M | 14.69% |
| Dec 31, 2006 | 1.27B | 92.95M | 7.87% |
| Dec 31, 2005 | 1.18B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BIO News
- 5 weeks ago - Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday - The Motley Fool
- 5 weeks ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Bio-Rad Reports Third-Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Compelling Value In Small-Cap Equities And Select Cyclicals - Seeking Alpha
- 6 weeks ago - 7 Stocks Taking The Next Step To Be On Offense - Seeking Alpha
- 6 weeks ago - It's time to scoop up undervalued stocks in this critical sector of the economy - Market Watch
- 7 weeks ago - Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 - Business Wire
- 3 months ago - Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc. - GlobeNewsWire